ID26403A - Amida baru yang tersubstitusi, pembuatan dan penggunaannya - Google Patents
Amida baru yang tersubstitusi, pembuatan dan penggunaannyaInfo
- Publication number
- ID26403A ID26403A IDW20002132A ID20002132A ID26403A ID 26403 A ID26403 A ID 26403A ID W20002132 A IDW20002132 A ID W20002132A ID 20002132 A ID20002132 A ID 20002132A ID 26403 A ID26403 A ID 26403A
- Authority
- ID
- Indonesia
- Prior art keywords
- alkyl
- substituted
- hydrogen
- phenyl
- branched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polyamides (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19818615 | 1998-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID26403A true ID26403A (id) | 2000-12-21 |
Family
ID=7865831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20002132A ID26403A (id) | 1998-04-20 | 1999-04-20 | Amida baru yang tersubstitusi, pembuatan dan penggunaannya |
Country Status (22)
Country | Link |
---|---|
US (4) | US6753327B1 (fr) |
EP (1) | EP1073641B1 (fr) |
JP (1) | JP4782924B2 (fr) |
KR (1) | KR20010042840A (fr) |
CN (1) | CN1306505A (fr) |
AT (1) | ATE264310T1 (fr) |
AU (1) | AU3927699A (fr) |
BG (1) | BG104873A (fr) |
BR (1) | BR9909774A (fr) |
CA (1) | CA2328396C (fr) |
DE (1) | DE59909183D1 (fr) |
ES (1) | ES2220061T3 (fr) |
HR (1) | HRP20000787A2 (fr) |
HU (1) | HUP0102732A3 (fr) |
ID (1) | ID26403A (fr) |
IL (1) | IL138703A0 (fr) |
NO (1) | NO20005263D0 (fr) |
PL (1) | PL343896A1 (fr) |
SK (1) | SK14512000A3 (fr) |
TR (1) | TR200003068T2 (fr) |
WO (1) | WO1999054310A2 (fr) |
ZA (1) | ZA200006719B (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19817459A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
JP4782924B2 (ja) | 1998-04-20 | 2011-09-28 | アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 新規の置換アミド、それらの製造および使用 |
DE59913973D1 (de) * | 1998-05-25 | 2006-12-21 | Abbott Gmbh & Co Kg | Heterocyclische substituierte Amide, deren Herstellung und Verwendung |
DE10114762A1 (de) * | 2001-03-26 | 2002-10-02 | Knoll Gmbh | Verwendung von Cysteinprotease-Inhibitoren |
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
US7282512B2 (en) | 2002-01-17 | 2007-10-16 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors |
ATE443043T1 (de) | 2002-11-12 | 2009-10-15 | Merck & Co Inc | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer |
PL220722B1 (pl) | 2002-12-20 | 2015-12-31 | Glaxo Group Ltd | Benzoazepinowe pochodne, zawierająca je kompozycja farmaceutyczna i ich zastosowania do wytwarzania leku i do leczenia chorób neurologicznych |
US20040204422A1 (en) | 2003-04-14 | 2004-10-14 | Abbott Gmbh & Co. Kg. | N-[(Piperazinyl)hetaryl]arylsulfonamide compounds |
TWI405571B (zh) | 2006-12-29 | 2013-08-21 | Abbott Gmbh & Co Kg | 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途 |
TWI453019B (zh) | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
US20100192866A1 (en) * | 2009-02-03 | 2010-08-05 | Mcmullen Joseph E | Disposable hummingbird feeder |
TWI519530B (zh) | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途 |
US8236798B2 (en) | 2009-05-07 | 2012-08-07 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors |
US9051304B2 (en) | 2009-12-22 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
US8598211B2 (en) | 2009-12-22 | 2013-12-03 | Abbvie Inc. | Carboxamide compounds and their use as calpain inhibitors IV |
GB2493120B (en) | 2010-04-30 | 2014-04-09 | Abbott Cardiovascular Systems | Improved balloon catheter exhibiting rapid inflation and deflation |
WO2012076639A1 (fr) | 2010-12-09 | 2012-06-14 | Abbott Gmbh & Co. Kg | Composés de carboxamide et leur utilisation comme inhibiteurs v de la calpaïne |
EP2834230A1 (fr) | 2012-04-03 | 2015-02-11 | AbbVie Deutschland GmbH & Co KG | Composés carboxamides et leur utilisation comme inhibiteurs de calpaïne v |
US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
WO2017156071A1 (fr) | 2016-03-09 | 2017-09-14 | Blade Therapeutics, Inc. | Composés céto-amides cycliques utilisés en tant que modulateurs de la calpaïne, et leurs procédés de production et d'utilisation |
US11292801B2 (en) | 2016-07-05 | 2022-04-05 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
CN110023304A (zh) | 2016-09-28 | 2019-07-16 | 布莱德治疗公司 | 钙蛋白酶调节剂及其治疗用途 |
WO2024018245A1 (fr) * | 2022-07-22 | 2024-01-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Utilisation d'inhibiteurs de calpaïne pour le traitement de la maladie rénale diabétique |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0564552A1 (fr) | 1990-12-28 | 1993-10-13 | Cortex Pharmaceuticals, Inc. | Utilisation d'inhibiteurs de la calpaine dans l'inhibition et le traitement de la neurodegenerescence |
EP0564561A4 (en) | 1990-12-28 | 1994-08-10 | Georgia Tech Res Inst | Peptides ketoamides, ketoacids, and ketoesters |
JP3280969B2 (ja) | 1991-04-10 | 2002-05-13 | メイヨ ファンデーション フォー メディカル エデュケーション アンド リサーチ | 可視光および紫外光の共焦点結像装置 |
CA2071621C (fr) * | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Derives d'aldehyde |
CA2138124A1 (fr) | 1992-06-24 | 1994-01-06 | David D. Eveleth, Jr. | Utilisation d'inhibiteurs de la calpaine pour inhiber et traiter des affections medicales associees a une augmentation de l'activite de la calpaine |
US5541290A (en) | 1993-06-24 | 1996-07-30 | Harbeson; Scott L. | Optically pure calpain inhibitor compounds |
JP3216458B2 (ja) | 1994-12-28 | 2001-10-09 | 富士レビオ株式会社 | アミド誘導体 |
DE19642591A1 (de) * | 1996-10-15 | 1998-04-16 | Basf Ag | Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung |
DE19817459A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
JP4782924B2 (ja) | 1998-04-20 | 2011-09-28 | アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 新規の置換アミド、それらの製造および使用 |
DE59913973D1 (de) * | 1998-05-25 | 2006-12-21 | Abbott Gmbh & Co Kg | Heterocyclische substituierte Amide, deren Herstellung und Verwendung |
-
1999
- 1999-04-20 JP JP2000544649A patent/JP4782924B2/ja not_active Expired - Fee Related
- 1999-04-20 ES ES99922108T patent/ES2220061T3/es not_active Expired - Lifetime
- 1999-04-20 CN CN99807639A patent/CN1306505A/zh active Pending
- 1999-04-20 ID IDW20002132A patent/ID26403A/id unknown
- 1999-04-20 BR BR9909774-5A patent/BR9909774A/pt not_active IP Right Cessation
- 1999-04-20 EP EP99922108A patent/EP1073641B1/fr not_active Expired - Lifetime
- 1999-04-20 SK SK1451-2000A patent/SK14512000A3/sk unknown
- 1999-04-20 PL PL99343896A patent/PL343896A1/xx unknown
- 1999-04-20 HU HU0102732A patent/HUP0102732A3/hu unknown
- 1999-04-20 US US09/673,089 patent/US6753327B1/en not_active Expired - Fee Related
- 1999-04-20 KR KR1020007011607A patent/KR20010042840A/ko not_active Application Discontinuation
- 1999-04-20 AT AT99922108T patent/ATE264310T1/de not_active IP Right Cessation
- 1999-04-20 AU AU39276/99A patent/AU3927699A/en not_active Abandoned
- 1999-04-20 WO PCT/EP1999/002633 patent/WO1999054310A2/fr not_active Application Discontinuation
- 1999-04-20 CA CA002328396A patent/CA2328396C/fr not_active Expired - Fee Related
- 1999-04-20 TR TR2000/03068T patent/TR200003068T2/xx unknown
- 1999-04-20 DE DE59909183T patent/DE59909183D1/de not_active Expired - Lifetime
- 1999-04-20 IL IL13870399A patent/IL138703A0/xx unknown
-
2000
- 2000-10-17 BG BG104873A patent/BG104873A/xx unknown
- 2000-10-19 NO NO20005263A patent/NO20005263D0/no not_active Application Discontinuation
- 2000-11-17 HR HR20000787A patent/HRP20000787A2/hr not_active Application Discontinuation
- 2000-11-17 ZA ZA200006719A patent/ZA200006719B/xx unknown
-
2003
- 2003-10-20 US US10/690,400 patent/US7276500B2/en not_active Expired - Fee Related
-
2007
- 2007-08-29 US US11/897,057 patent/US7956093B2/en not_active Expired - Fee Related
-
2010
- 2010-10-29 US US12/915,680 patent/US20110275615A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20005263L (no) | 2000-10-19 |
BG104873A (en) | 2001-07-31 |
TR200003068T2 (tr) | 2001-03-21 |
CN1306505A (zh) | 2001-08-01 |
HUP0102732A2 (hu) | 2001-12-28 |
DE59909183D1 (de) | 2004-05-19 |
IL138703A0 (en) | 2001-10-31 |
HRP20000787A2 (en) | 2001-08-31 |
JP4782924B2 (ja) | 2011-09-28 |
NO20005263D0 (no) | 2000-10-19 |
ATE264310T1 (de) | 2004-04-15 |
US7276500B2 (en) | 2007-10-02 |
US20080113989A1 (en) | 2008-05-15 |
BR9909774A (pt) | 2000-12-19 |
EP1073641B1 (fr) | 2004-04-14 |
AU3927699A (en) | 1999-11-08 |
US7956093B2 (en) | 2011-06-07 |
WO1999054310A3 (fr) | 2000-02-17 |
PL343896A1 (en) | 2001-09-10 |
US20040082569A1 (en) | 2004-04-29 |
WO1999054310A2 (fr) | 1999-10-28 |
HUP0102732A3 (en) | 2002-12-28 |
CA2328396C (fr) | 2009-02-10 |
SK14512000A3 (sk) | 2001-04-09 |
US6753327B1 (en) | 2004-06-22 |
CA2328396A1 (fr) | 1999-10-28 |
KR20010042840A (ko) | 2001-05-25 |
US20110275615A1 (en) | 2011-11-10 |
ES2220061T3 (es) | 2004-12-01 |
EP1073641A2 (fr) | 2001-02-07 |
ZA200006719B (en) | 2002-08-15 |
JP2002512231A (ja) | 2002-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID26403A (id) | Amida baru yang tersubstitusi, pembuatan dan penggunaannya | |
NZ533310A (en) | Benzimidazoles useful as protein kinase inhibitors | |
CO5140126A1 (es) | 2-fenilbenzimidazoles sustituidos, su obtencion y uso | |
DE69413414D1 (de) | Substituierte phenylverbindungen | |
TW326447B (en) | Substituted 2-phenylpyridines, intermediates and process for their preparation and application thereof | |
NZ335973A (en) | Indane or dihydroindole derivatives and their use in treating neurological and cardiovascular disorders | |
RS50889B (sr) | Derivati diaril-cikloalkila, postupak za njihovu proizvodnju i njihova primena u svojstvu ppar aktivatora | |
GB9005014D0 (en) | N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives | |
ZA896626B (en) | Antidepressant n-substituted nicotinamide compounds | |
NZ336302A (en) | Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia | |
NO994115L (no) | Nye 1,4-diazacykloheptanderivater og deres anvendelse i haaroksydasjonsfargestoffer | |
AP2001002265A0 (en) | Phenoxybenzylamine derivatives as SSRIs. | |
BG103992A (en) | Acetidinylpropylpiperidine derivatives, intermediate compounds and their application as tachyquinine antagonists | |
DE60022227D1 (de) | 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung | |
FI913957A0 (fi) | 6,7-dihydro-3-fenyl-1,2 -bensisoxazol-4(5h)-oner och -oler, foerfarande foer framstaellning av dessa samt anvaendning av dessa som laekemedel. | |
YU48949B (sh) | Benzopiran i srodni ltb-antagonisti | |
BG102959A (en) | Benzooxazinon antagonists of domamine d4 receptor | |
TW340109B (en) | Amide derivatives and their therapeutic use | |
YU84901A (sh) | Derivati 4-fenil-pirimidina | |
DE50211985D1 (de) | Verwendung von pyridin-2,4-dicarbons urediamiden und pyrimid in-4,6-dicarbons urediamiden zur selektiven inhibierung von kollagenasen | |
HUP0002249A2 (hu) | Pirimidin- és triazinszármazékok alkalmazása rákellenes gyógyszerkészítmények előállítására | |
GB8306033D0 (en) | 4-phenyl-4,5,6,7-tetrahydro-thieno 2,3-c pyridines | |
EA200600171A1 (ru) | 3-замещенные пиримидины | |
FR2543139B1 (fr) | Derives de (1-alcoxy 2-amino) ethyl pyridine ou pyrazine, leur preparation et leur application en therapeutique | |
NZ335975A (en) | Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases |